ArticleCureus2025
Managing Placenta Accreta Spectrum: Diagnosis, Surgical Strategies, and Postoperative Care.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Placenta accreta spectrum (PAS) refers to a group of disorders characterized by abnormal trophoblastic invasion of the uterine wall, which can result in life-threatening complications such as severe hemorrhage and the need for hysterectomy. A 30-year-old female patient with a history of two prior cesarean sections and diagnosed with Grade IV placenta previa at 34+0 weeks gestation was referred to our hospital for management. The patient presented with antepartum hemorrhage and was at elevated risk for PAS due to her previous cesarean sections and placenta previa. Ultrasound findings suggested PAS, including hypervascularity, consistent with trophoblastic invasion. Elective cesarean section was performed, and intraoperatively, focal accreta was identified with manual removal of the placenta and bilateral uterine artery ligation to control hemorrhage. Histopathology confirmed myometrial tissue with hemorrhage and dilated blood vessels, consistent with PAS, but without evidence of malignancy. The patient was managed in a multidisciplinary setting and received postoperative care for bleeding complications related to Factor 12 deficiency. Her recovery was uneventful, and she was discharged on postoperative day 3. This case highlights the importance of early diagnosis, imaging, and multidisciplinary management in optimizing maternal and fetal outcomes in PAS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.